An integrated framework for identifying clinical-laboratory indicators for novel pandemics: COVID-19 and MIS-C

During the critical early stages of an emerging pandemic, limited availability of pathogen-specific testing can severely inhibit individualized risk screening and pandemic tracking. Standard clinical laboratory tests offer a widely available complementary data source for first-line risk screening an...

Descripción completa

Detalles Bibliográficos
Autores principales: Nahari, Adam D., Son, Mary Beth F., Newburger, Jane W., Reis, Ben Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776774/
https://www.ncbi.nlm.nih.gov/pubmed/35058541
http://dx.doi.org/10.1038/s41746-021-00547-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776774/
https://www.ncbi.nlm.nih.gov/pubmed/35058541
http://dx.doi.org/10.1038/s41746-021-00547-9

Ejemplares similares